Clinical Trial Update: Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN) [Phase 2]

View source ↗

Summary

Phase 2 trial in rectal cancer evaluating neoadjuvant radiotherapy followed by atezolizumab and bevacizumab. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Rectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING